Incidence of ras gene mutations in neuroblastoma - PubMed (original) (raw)
Incidence of ras gene mutations in neuroblastoma
K Ballas et al. Eur J Pediatr. 1988 Apr.
Abstract
Using a rapid dot-blot screening procedure based on DNA amplification and hybridization to synthetic oligonucleotide probes, we investigated 18 neuroblastomas in various clinical stages for the presence of ras mutations. In none of the samples was a mutation in the relevant codons 12, 13 or 61 of Ha-ras, Ki-ras or N-ras found. These data virtually exclude the participation of mutated ras genes in the genesis of neuroblastoma.
Similar articles
- Activated N-ras oncogenes in human neuroblastoma.
Ireland CM. Ireland CM. Cancer Res. 1989 Oct 15;49(20):5530-3. Cancer Res. 1989. PMID: 2676145 - Infrequent point mutations of ras oncogenes in gastric cancers.
Nanus DM, Kelsen DP, Mentle IR, Altorki N, Albino AP. Nanus DM, et al. Gastroenterology. 1990 Apr;98(4):955-60. doi: 10.1016/0016-5085(90)90019-w. Gastroenterology. 1990. PMID: 2179035 - Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG, Mohan RR, Katiyar SK, Wood GS, Bickers DR, Mukhtar H, Agarwal R. Khan SG, et al. Mol Carcinog. 1996 Feb;15(2):96-103. doi: 10.1002/(SICI)1098-2744(199602)15:2<96::AID-MC2>3.0.CO;2-P. Mol Carcinog. 1996. PMID: 8599584 - Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
Tsuchida Y, Hemmi H, Inoue A, Obana K, Yang HW, Hayashi Y, Kanda N, Shimatake H. Tsuchida Y, et al. Tumour Biol. 1996;17(2):65-74. doi: 10.1159/000217968. Tumour Biol. 1996. PMID: 8658015 Review. - Targeting RAS in neuroblastoma: Is it possible?
Lin L, Miao L, Lin H, Cheng J, Li M, Zhuo Z, He J. Lin L, et al. Pharmacol Ther. 2022 Aug;236:108054. doi: 10.1016/j.pharmthera.2021.108054. Epub 2021 Dec 13. Pharmacol Ther. 2022. PMID: 34915055 Review.
Cited by
- TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
Gneo L, Ruggeri P, Cappabianca L, Farina AR, Di Ianni N, Mackay AR. Gneo L, et al. Oncotarget. 2016 Dec 6;7(49):80820-80841. doi: 10.18632/oncotarget.13098. Oncotarget. 2016. PMID: 27821809 Free PMC article. - Mutations in PIK3CA are infrequent in neuroblastoma.
Dam V, Morgan BT, Mazanek P, Hogarty MD. Dam V, et al. BMC Cancer. 2006 Jul 5;6:177. doi: 10.1186/1471-2407-6-177. BMC Cancer. 2006. PMID: 16822308 Free PMC article. - Dissecting Intra-Tumor Heterogeneity by the Analysis of Copy Number Variations in Single Cells: The Neuroblastoma Case Study.
Cariati F, Borrillo F, Shankar V, Nunziato M, D'Argenio V, Tomaiuolo R. Cariati F, et al. Int J Mol Sci. 2019 Feb 19;20(4):893. doi: 10.3390/ijms20040893. Int J Mol Sci. 2019. PMID: 30791380 Free PMC article. - Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways.
Shukla N, Ameur N, Yilmaz I, Nafa K, Lau CY, Marchetti A, Borsu L, Barr FG, Ladanyi M. Shukla N, et al. Clin Cancer Res. 2012 Feb 1;18(3):748-57. doi: 10.1158/1078-0432.CCR-11-2056. Epub 2011 Dec 5. Clin Cancer Res. 2012. PMID: 22142829 Free PMC article. - Biology of tumors of the peripheral nervous system.
Brodeur GM, Moley JF. Brodeur GM, et al. Cancer Metastasis Rev. 1991 Dec;10(4):321-33. doi: 10.1007/BF00554794. Cancer Metastasis Rev. 1991. PMID: 1786633 Review.
References
- Gene. 1986;50(1-3):313-20 - PubMed
- Oncogene. 1987 May;1(2):175-9 - PubMed
- Nucleic Acids Res. 1987 Jul 24;15(14):5669-80 - PubMed
- Nature. 1987 May 28-Jun 3;327(6120):293-7 - PubMed
- Annu Rev Biochem. 1987;56:779-827 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous